Smoking cessation interventions: A primer for physicians

Archives of Internal Medicine

Volumn 171, Issue 8, 2011, Pages 777-778

  Simon, Joel A ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; VARENICLINE;

CIGARETTE SMOKING; COUNSELING; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HUMAN; MORNING DOSAGE; NICOTINE REPLACEMENT THERAPY; NOTE; PHYSICIAN; PRIORITY JOURNAL; PROBABILITY; SMOKING CESSATION; TOBACCO DEPENDENCE; TREATMENT DURATION;

BENZAZEPINES; BUPROPION; CHEWING GUM; COUNSELING; DELAYED-ACTION PREPARATIONS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HUMANS; NASAL SPRAYS; NEBULIZERS AND VAPORIZERS; NICOTINE; NICOTINIC AGONISTS; QUINOXALINES; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS; TRANSDERMAL PATCH; TREATMENT OUTCOME;

EID: 79955757375     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2011.137     Document Type: Note

References (15)

1. Centers for Disease Control and Prevention (CDC). State-specific prevalence and trends in adult cigarette smoking-United States, 1998-2007.MMWR Morb Mortal Wkly Rep. 2009;58(9):221-226.
2. Centers for Disease Control and Prevention (CDC). Vital signs: current cigarette smoking among adults aged _18 years United States, 2009. MMWR Morb Mortal Wkly Rep. 2010;59(35):1135-1140.
3. Fiore MC, Jae'n CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update: Clinical Practice Guideline. Rockville, MD: Public Health Service, US Dept of Health and Human Services; May 2008.
4. Hurt RD, Ebbert JO, Hays JT, McFadden DD. Treating tobacco dependence in a medical setting. CA Cancer J Clin. 2009;59(5):314-326.
5. Stead LF, Bergson G, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2008;(2):CD000165.
6. Hughes JR. Tobacco treatment specialist: a new profession. J Smoking Cessation. 2007;2(suppl):2-7.
7. Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2008;(1):CD000146.
8. Rigotti NA, Munafo MR, Stead LF. Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev. 2007;(3):CD001837.
9. Hurt RD, Isaacs SL, Schroeder SA, Simon JA, eds. Treating tobacco dependence in a medical setting: best practices. In:VA in the Vanguard: Building on Success in Smoking Cessation. Bethesda, MD: Dept of Veterans Affairs; 2005: 43-76.
10. Tsoi DT, Porwal M, Webster AC. Efficacy and safety of bupropion for smoking cessation and reduction in schizophrenia: systematic review and meta-analysis. Br J Psychiatry. 2010;196(5):346-353.
11. Roddy E. Bupropion and other non-nicotine pharmacotherapies. BMJ. 2004; 328(7438):509-511.
12. Hays JT, Ebbert JO. Varenicline for tobacco dependence. N Engl JMed. 2008; 359(19):2018-2024.
13. Steinberg MB, Greenhaus S, Schmelzer AC, et al. Triple-combination pharmacotherapy for medically ill smokers: a randomized trial. Ann Intern Med. 2009;150(7):447-454.
14. Hays JT, Ebbert JO, Sood A. Treating tobacco dependence in light of the 2008 US Department of Health and Human Services clinical practice guideline. Mayo Clin Proc. 2009;84(8):730-735, quiz 735-736.
15. Steinberg MB, Schmelzer AC, Richardson DL, Foulds J. The case for treating tobacco dependence as a chronic disease. Ann Intern Med. 2008;148 (7):554-556.